Skip to content

+358 20 7446 800 

  • English
  • Suomi

Search

Show search form

Medfiles
  • Company
    • About us
    • History
    • Medfiles’ team leaders
    • Management team
  • Our Services
        • Human Medicines
          • Regulatory Affairs
            • CMC
            • New Marketing Authorisations
            • Marketing Authorisation Maintenance
            • Local Regulatory Affairs
          • Pharmacovigilance
            • PV System Set Up
            • Post-Authorisation
            • ICSR
            • QPPV
            • Medical Information
          • Clinical Trials
            • Clinical Trial Safety
        • Veterinary Medicines
          • Marketing Authorisation & PV Readiness
          • Regulatory Affairs
            • CMC
            • New Marketing Authorisations
            • Marketing Authorisation Maintenance
            • Local Regulatory Affairs
          • Pharmacovigilance
            • PV System Set Up
            • Post-Authorisation
            • Adverse Event Prosessing
            • QPPV
        • Medical Device & IVDS
          • Quality & Regulatory
            • QMS
            • Technical Documentation
            • Clinical and Performance Evaluations
            • Registrations
            • Post-Market Services
            • Labelling, Translations & Marketing Materials
          • Clinical Investigations and Performance Studies
          • Post-Authorisation & Clinical Vigilance
        • Drug-device combinations
          • Strategy and classification
          • Development, documentation and regulatory alignment
          • Clinical trials and investigations
          • CMC
          • Approvals and conformity
          • Safety & PMS
          • Lifecycle management
        • Food
          • Novel Foods
          • GRAS, NDI and FAP
          • Health Claims
          • Food and Food Supplement Labelling and Marketing Materials
          • FSGs and FSMPs
          • Regulatory Positioning and Strategies
          • Clinical Studies
        • Feed
          • Regulatory Positioning and Strategies
          • Feed Material and Additive Registrations
          • GRAS and FAP
          • Labelling and Marketing Materials
          • Feed for Particular Nutritional Purposes
  • Insights
  • Careers
  • Contact us
    • Contact form
    • Contact our units
    • Offices
    • Invoicing

Service: Pharmacovigilance (human medicines)

  • New CTIS Safety Module for Annual Safety Reports goes live on 28 September 2026

    09.09.2026

    CTIS safety module
  • Additional risk minimisation measures (aRMMs) – from requirement to implementation

    24.07.2026

    Additional risk minimisation measure
  • Embedded expert support for RA & PV teams: a flexible alternative to hiring and full outsourcing

    13.05.2026

    Embedded expert support
  • Global healthcare company & Medfiles: ensuring quality and continuity in post-approval RA and PV activities

    04.05.2026

    Medfiles news and events
  • How do post-marketing drug safety practices differ between Japan, the US, and the EU

    07.04.2026

    post-marketing drug safety practices
  • What are the MAH’s post-authorisation pharmacovigilance responsibilities

    10.03.2026

  • Major pharmacovigilance reform: EU Regulation 2025/1466 sets new standards for MAHs

    12.02.2026

    EU Regulation 2025/1466
  • Looking for a reliable medical information service provider?

    16.01.2026

    medical information service
  • Medfiles and LINK Medical: partners in regulatory and pharmacovigilance services in Northern Europe

    28.05.2025

1 2 Next
Medfiles - Securing a healthier tomorrow

© 2026 Copyright Medfiles.
All rights reserved.

Privacy Policy
Notification Channel

WDB Group

Services

Human medicine
Veterinary medicine
Medical Device & IVD
Drug-device combinations
Food
Feed

Contact

Rajatorpantie 41 C, FI-01640 Vantaa, Finland
VAT: FI10475691

+358 20 7446 800

Contact form
Subscribe to our Newsletter

© 2026 Medfiles • Built with GeneratePress